Cargando…

Toll-Like Receptor 7 Mediates Inflammation Resolution and Inhibition of Angiogenesis in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The progression of cancer is strictly linked to the formation of new blood vessels responsible for nutrition supply of the tumor. We identified TLR7 as an inhibitor of lung cancer vascularization. TLR7 is part of a large family of immune receptors that function as “sensors” of pathog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liotti, Federica, Marotta, Maria, Sorriento, Daniela, Pone, Emanuela, Morra, Francesco, Melillo, Rosa Marina, Prevete, Nella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916730/ https://www.ncbi.nlm.nih.gov/pubmed/33578955 http://dx.doi.org/10.3390/cancers13040740

Ejemplares similares

The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression
por: Liotti, Federica, et al.
Publicado: (2022)

Probiotic Lactobacillus rhamnosus GG (LGG) restrains the angiogenic potential of colorectal carcinoma cells by activating a proresolving program via formyl peptide receptor 1
por: Liotti, Federica, et al.
Publicado: (2022)

Recent advances in understanding immune phenotypes of thyroid carcinomas: prognostication and emerging therapies
por: Liotti, Federica, et al.
Publicado: (2019)

Multiple anti-tumor effects of Reparixin on thyroid cancer
por: Liotti, Federica, et al.
Publicado: (2017)

PD-1 blockade delays tumor growth by inhibiting an intrinsic SHP2/Ras/MAPK signalling in thyroid cancer cells
por: Liotti, Federica, et al.
Publicado: (2021)

Tumor-Associated Mast Cells in Thyroid Cancer
por: Visciano, Carla, et al.
Publicado: (2015)

The lncRNA RMST is drastically downregulated in anaplastic thyroid carcinomas where exerts a tumor suppressor activity impairing epithelial-mesenchymal transition and stemness
por: De Martino, Marco, et al.
Publicado: (2023)

Parathyroid Hormone Causes Endothelial Dysfunction by Inducing Mitochondrial ROS and Specific Oxidative Signal Transduction Modifications
por: Gambardella, Jessica, et al.
Publicado: (2018)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-Like Receptor 4 in Inflammation and Angiogenesis: A Double-Edged Sword
por: Murad, Sheeba
Publicado: (2014)

Glucose Enhances Pro-Tumorigenic Functions of Mammary Adipose-Derived Mesenchymal Stromal/Stem Cells on Breast Cancer Cell Lines
por: Ambrosio, Maria Rosaria, et al.
Publicado: (2022)

GRK2 moderates the acute mitochondrial damage to ionizing radiation exposure by promoting mitochondrial fission/fusion
por: Franco, Antonietta, et al.
Publicado: (2018)

Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation
por: Koltsida, Ourania, et al.
Publicado: (2013)

AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer
por: Collina, Francesca, et al.
Publicado: (2019)

Rhododendrin inhibits toll-like receptor-7-mediated psoriasis-like skin inflammation in mice
por: Jeon, Yoon-Jae, et al.
Publicado: (2017)

Toll-Like Receptors and Myocardial Inflammation
por: Feng, Yan, et al.
Publicado: (2011)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

In PD-1+ human colon cancer cells NIVOLUMAB promotes survival and could protect tumor cells from conventional therapies
por: Ieranò, Caterina, et al.
Publicado: (2022)

Dissecting the role of toll‐like receptor 7 in pancreatic cancer
por: Stark, Maren, et al.
Publicado: (2023)

Toll-like Receptor 2 in Autoimmune Inflammation
por: Marks, Kathryne E., et al.
Publicado: (2021)

Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
por: Patlola, Saahithh Redddi, et al.
Publicado: (2023)

Inflammation and Cardiovascular Diseases: The Most Recent Findings
por: Sorriento, Daniela, et al.
Publicado: (2019)

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
por: Cen, Xiaohong, et al.
Publicado: (2018)

Reply to Comment on “Malfitano, A.M. et al. Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer” Cancers 2019, 11, 1532
por: Malfitano, Anna Maria, et al.
Publicado: (2020)

Virotherapy as a Potential Therapeutic Approach for the Treatment of Aggressive Thyroid Cancer
por: Malfitano, Anna Maria, et al.
Publicado: (2019)

Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation
por: Managò, Antonella, et al.
Publicado: (2019)

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer
por: Carbone, Carmine, et al.
Publicado: (2018)

Placental Toll-Like Receptor 3 and Toll-Like Receptor 7/8 Activation Contributes to Preeclampsia in Humans and Mice
por: Chatterjee, Piyali, et al.
Publicado: (2012)

Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
por: Kaczorowski, David J, et al.
Publicado: (2009)

Toll-Like Receptors are critical in controlling colonic inflammation and cancer
por: Xiao, Hui, et al.
Publicado: (2011)

The role of toll-like receptors in acute and chronic lung inflammation
por: Lafferty, Erin I, et al.
Publicado: (2010)

Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation
por: Wang, James Q., et al.
Publicado: (2014)

Toll-like receptor activation: from renal inflammation to fibrosis
por: Yiu, Wai Han, et al.
Publicado: (2014)

The emerging role of Toll-like receptor 4 in myocardial inflammation
por: Yang, Y, et al.
Publicado: (2016)

Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease
por: García-Rodríguez, Carmen, et al.
Publicado: (2018)

Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
por: Rogero, Marcelo Macedo, et al.
Publicado: (2018)

The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation
por: Molteni, Monica, et al.
Publicado: (2016)

Going, Toll-like receptors in skin inflammation and inflammatory diseases
por: Kumar, Vijay
Publicado: (2021)

Toll-like receptor 4 deficiency in mice impairs venous thrombus resolution
por: Yuan, Haixin, et al.
Publicado: (2023)

Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
por: Damiano, V, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uscfvl3mq08bijpslh8dopn79v